Drugs / 4Fluart ID
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03448705 | Jan → Apr 2018 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4Fluart ID | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03448705 ↗ |
| Known as | 4Fluart ID suspension for injection study drug | “4Fluart ID suspension for injection study drug” NCT03448705 ↗ |
| Modality | Vaccine | “influenza vaccine (whole virion, inactivated, adjuvanted)” NCT03448705 ↗ |
| Route | Other | “Route of administration: intradermal” NCT03448705 ↗ |